Acepodia (ROCO:6976) EBITDA Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Acepodia EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Acepodia's EBITDA for the six months ended in Jun. 2023 was NT$-597.35 Mil. Acepodia's Revenue for the six months ended in Jun. 2023 was NT$0.00 Mil. Therefore, Acepodia's EBITDA margin for the quarter that ended in Jun. 2023 was 0.00%.

Acepodia EBITDA Margin % Historical Data

The historical data trend for Acepodia's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia EBITDA Margin % Chart

Acepodia Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-4,607.48

Acepodia Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Acepodia's EBITDA Margin %

For the Biotechnology subindustry, Acepodia's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acepodia's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Acepodia's EBITDA Margin % falls into.

Acepodia EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Acepodia's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-764.519	/	16.593
	=	-4,607.48 %

Acepodia's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-597.345	/	0
	=	%

Acepodia (ROCO:6976) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Acepodia EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Acepodia's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acepodia (ROCO:6976) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175

Website

https://www.acepodia.com

Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines